The Brisbane Heat club have been proud partners with Ovarian Cancer Australia since 2014 and are currently fund-raising as part of Ovarian Cancer Awareness Month.
WBBL Brisbane Heat wicket-keeper Georgia Redmayne provided a message of support through the club’s social media channels.
Redmayne, a doctor, said events like Teal Ribbon Day were vital in raising awareness of the disease, which is the deadliest female cancer in Australia.
Brisbane Heat players in the rebel Women’s Big Bash League and KFC Big Bash League displayed their zeal for teal by wearing teal ribbons on the playing apparel during some matches in their respective competitions this summer.
Queensland Cricket CEO Terry Svenson said the Heat continued to make a difference to the lives of Australian women by championing the goals of Ovarian Cancer Australia and raising vital funds for treatment, research, and support.
“Ovarian Cancer Australia has been a great partner of Queensland Cricket and the Brisbane Heat for a number of years and we’re proud to make our contribution to a day like Teal Ribbon Day that helps put the spotlight on ovarian cancer symptoms and awareness,’’ he said.
“We are pleased for the Brisbane Heat and QC to again be able to raise much-needed funds and awareness for the many Australian women living with ovarian cancer.”
The club is running a fundraising auction with proceeds from the 12 autographed player and team jumpers, plus items from OCA supporters such as a Sealy Posturepidic queen sized bed, an Interflora 12-month florist subscription, and a Bonds, Bras N Things, Jockey and Destination Derriere Ladies Apparel Pack on offer, with all money raised to be donated to Ovarian Cancer Australia, the Heat's official charity partner.
The Heat have set a target of raising more than $15,000 by today which is Teal Ribbon Day nationally.
As well as the jersey auction, Queensland Cricket have participated in several community and club fund-raising events in regional Queensland.
Ovarian cancer is the deadliest female cancer in Australia with a low 46% survival rate.